Regeneron Pharmaceuticals (REGN) Adjusts Course Amid Mixed Results in Melanoma Drug Trials
finance.yahoo.com
27.08.2026 14:43
1 baxış
Əlaqəli xəbərlər
BlackRock Sees Continued Strength In Bitcoin
finance.yahoo.com · 27.08
Google moves AI responsibility team out of DeepMind
finance.yahoo.com · 27.08
Why Figure Could Be One of Crypto’s Most Undervalued Stocks
finance.yahoo.com · 27.08
Salesforce Soars 14% as Claudeforce and a Guidance Raise End the Slump, ServiceNow Climbs 5%, Adobe Advances 3%
finance.yahoo.com · 27.08
The Kohl’s Recesson
finance.yahoo.com · 27.08
Futu ( FUTU) Posts Record Quarter Despite Regulatory Headwinds
finance.yahoo.com · 27.08